Sandoz To Invest New Biosimilar Facility In Slovenia

(RTTNews) - Sandoz Group AG (SDZ.SW, SDZNY) on Tuesday said it plans to invest around $300 million to build a new biosimilar manufacturing facility in Ljubljana, Slovenia.

By Dhallo News · September 8, 2026 at 1:27 PM IST

(RTTNews) - Sandoz Group AG (SDZ.SW, SDZNY) on Tuesday said it plans to invest around

$300 million to build a new biosimilar manufacturing facility in Ljubljana, Slovenia.

SOURCE: Nasdaq

ORIGINAL REPORT: Click here

DHALLO EDITORIAL STATUS: Aggregated & reviewed

Have feedback on this article?Report error or suggestion

Sandoz To Invest New Biosimilar Facility In Slovenia

Read More from Markets

Brent Oil Climbs Toward $100 With Hormuz Constrained (Video)

Philippines unveils AI infrastructure plan to forge niche as regional hub

Bulls, bears slug it out as Nifty nears key support

5 minutes. The news that matters.